InvestorsHub Logo
Followers 10
Posts 3124
Boards Moderated 1
Alias Born 04/20/2001

Re: blackbandit post# 15

Tuesday, 02/02/2016 8:06:48 AM

Tuesday, February 02, 2016 8:06:48 AM

Post# of 37
7:05 am Emerson beats by $0.05, beats on revs; guides Q2 EPS in-line; reaffirms FY16 EPS guidance (EMR) :
•Reports Q1 (Dec) earnings of $0.56 per share, excluding non-recurring items, $0.05 better than the Capital IQ Consensus of $0.51; revenues fell 15.6% year/year to $4.71 bln vs the $4.62 bln Capital IQ Consensus.
•Co issues in-line guidance for Q2, sees EPS of $0.60-0.65 vs. $0.65 Capital IQ Consensus Estimate; sales for the second quarter are expected to decline 8-10% vs consensus of -10%.
•Co reaffirms EPS guidance for FY16, sees EPS of $3.05-3.25 vs. $3.05 Capital IQ Consensus Estimate; reported sales for 2016 are still expected decline 6-9% vs prior guidance of down 6-8%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EMR News